A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland

被引:155
作者
Kritikou, EA
Sharkey, A
Abell, K
Came, PJ
Anderson, E
Clarkson, RWE
Watson, CJ
机构
[1] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[2] Christie Hosp NHS Trust, Dept Clin Res, Manchester M20 4BX, Lancs, England
来源
DEVELOPMENT | 2003年 / 130卷 / 15期
关键词
LIF; mammary development; STAT3; apoptosis; ERK; mouse;
D O I
10.1242/dev.00578
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
STAT3 is the key mediator of apoptosis in mammary gland. We demonstrate here that LIF is the physiological activator of STAT3, because in involuting mammary glands of Lif(-/-) mice, pSTAT3 is absent and the STAT3 target, C/EBPdelta, is not upregulated. Similar to Stat3 knockouts, Lif(-/-) mammary glands exhibit delayed involution, reduced apoptosis and elevated levels of p53. Significantly, Lif(-/-) glands display precocious development during pregnancy, when pSTAT3 is not normally detected. We show that pERK1/2 is significantly reduced in Lif(-/-) glands at this time, suggesting that at this stage LIF mediates its effects through pERK1/2. Inhibition of LIF-mediated ERK1/2 phosphorylation potentiates the proapoptotic effects of STAT3. LIF therefore signals alternately through ERK1/2, then STAT3, to regulate mammary growth and apoptosis.
引用
收藏
页码:3459 / 3468
页数:10
相关论文
共 38 条
[1]   Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade [J].
Aubert, J ;
Dessolin, S ;
Belmonte, N ;
Li, M ;
McKenzie, FR ;
Staccini, L ;
Villageois, P ;
Barhanin, B ;
Vernallis, A ;
Smith, AG ;
Ailhaud, G ;
Dani, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (35) :24965-24972
[2]   Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter [J].
Auernhammer, CJ ;
Bousquet, C ;
Melmed, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6964-6969
[3]   Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion [J].
Auernhammer, CJ ;
Chesnokova, V ;
Bousquet, C ;
Melmed, S .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (07) :954-961
[4]   Differential regulation of the human 'leukemia inhibitory factor' (LIF) promoter in T47D and MDA-MB 231 breast cancer cells [J].
Bamberger, AM ;
Thuneke, I ;
Schulte, HM .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 47 (02) :153-161
[5]   UTERINE EXPRESSION OF LEUKEMIA INHIBITORY FACTOR COINCIDES WITH THE ONSET OF BLASTOCYST IMPLANTATION [J].
BHATT, H ;
BRUNET, LJ ;
STEWART, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11408-11412
[6]   Induction of mammary gland development in estrogen receptor-α knockout mice [J].
Bocchinfuso, WP ;
Lindzey, JK ;
Hewitt, SC ;
Clark, JA ;
Myers, PH ;
Cooper, R ;
Korach, KS .
ENDOCRINOLOGY, 2000, 141 (08) :2982-2994
[7]   Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor [J].
Bousquet, C ;
Susini, C ;
Melmed, S .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (09) :1277-1285
[8]   Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3 [J].
Chapman, RS ;
Lourenco, PC ;
Tonner, E ;
Elint, DJ ;
Selbert, S ;
Takeda, K ;
Akira, S ;
Clarke, AR ;
Watson, CJ .
GENES & DEVELOPMENT, 1999, 13 (19) :2604-2616
[9]   Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis [J].
Chen, JR ;
Cheng, JG ;
Shatzer, T ;
Sewell, L ;
Hernandez, L ;
Stewart, CL .
ENDOCRINOLOGY, 2000, 141 (12) :4365-4372
[10]   Physics-based modeling and real-time simulation [J].
Chen, JX ;
Yang, YG ;
Wang, XS .
COMPUTING IN SCIENCE & ENGINEERING, 2001, 3 (03) :98-102